Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
"
Straits Research has added a new report entitled "Aphrodisiac Powder Market Professional Report 2021" to its extensive repository of research reports. This is a...